Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
Former US first lady Rosalynn Carter to lie in repose in Georgia
Post Content Post Views: 133
HP CEO: Growth in PC segment likely to double next year
Post Content Post Views: 145
Cryptocurrency market sees mixed results with KILT Protocol and Kitty Inu up
Post Content Post Views: 105
Goldman Sachs raises Adani Ports target to Rs 855 on strong H2 outlook
Post Content Post Views: 118
Fed Chair Powell calls talk of cutting rates ‘premature’ and says more hikes could happen
Federal Reserve Chairman Jerome Powell on Friday pushed back on market expectations for aggressive interest rate cuts ahead. Post Views: 118
Gamehost sets ex-dividend date for November 29 with CA$0.04 payout
Post Content Post Views: 106